{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T05:16:07Z","timestamp":1771996567034,"version":"3.50.1"},"reference-count":65,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"DOI":"10.3389\/fncel.2015.00344","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T12:28:02Z","timestamp":1441628882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke"],"prefix":"10.3389","volume":"9","author":[{"given":"Arun Paul","family":"Amar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berislav V.","family":"Zlokovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"B3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3174\/ajnr.a3707","article-title":"Complications of endovascular treatment for acute stroke in the SWIFT trial with solitaire and Merci devices","volume":"35","author":"Akins","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3174\/ajnr.a3855","article-title":"Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using solitaire FR in acute ischemic stroke study","volume":"35","author":"Almekhlafi","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1227\/01.neu.0000043698.86548.a0","article-title":"Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system","volume":"52","author":"Amar","year":"2003","journal-title":"Neurosurgery"},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/ijs.12434","article-title":"Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage and edema","volume":"10","author":"Bai","year":"2015","journal-title":"Int. J. Stroke."},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/strokeaha.110.592535","article-title":"Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action","volume":"41","author":"Bhatia","year":"2010","journal-title":"Stroke"},{"key":"B9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1214300","article-title":"Endovascular therapy after intravenous t-PA versus t-PA alone for stroke","volume":"368","author":"Broderick","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nm826","article-title":"Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective","volume":"9","author":"Cheng","year":"2003","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/nm1498","article-title":"Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage","volume":"12","author":"Cheng","year":"2006","journal-title":"Nat. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1213701","article-title":"Endovascular treatment for acute ischemic stroke","volume":"368","author":"Ciccone","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/jcbfm.2008.117","article-title":"Endothelial protein C receptor-assisted transport of activated protein C across the mouse blood-brain barrier","volume":"29","author":"Deane","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm0298-148","article-title":"tPA: a neuron buster, too?","volume":"4","author":"del Zoppo","year":"1998","journal-title":"Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.str.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.1182\/blood-2002-12-3680","article-title":"Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1","volume":"101","author":"Domotor","year":"2003","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(95)92689-5","article-title":"Streptokinase in acute ischaemic stroke. Steering committees of the ASK and MAST-E trials. Australian streptokinase trial","volume":"346","author":"Donnan","year":"1995","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke. The atherosclerosis risk in communities (ARIC) study investigators","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1161\/STROKEAHA.108.528877","article-title":"Current status of neuroprotection for cerebral ischemia: synoptic overview","volume":"40","author":"Ginsberg","year":"2009","journal-title":"Stroke"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.neuroscience.2009.11.027","article-title":"Activated protein C prevents glutamate- and thrombin-induced activation of nuclear factor-kappaB in cultured hippocampal neurons","volume":"165","author":"Gorbacheva","year":"2010","journal-title":"Neuroscience"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1053\/shem.2002.34093","article-title":"Activated protein C: potential therapy for severe sepsis, thrombosis and stroke","volume":"39","author":"Griffin","year":"2002","journal-title":"Semin. Hematol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/s0140-6736(12)60768-5","article-title":"The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial","volume":"379","author":"Group","year":"2012","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/s0896-6273(04)00019-4","article-title":"Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3","volume":"41","author":"Guo","year":"2004","journal-title":"Neuron"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1523\/JNEUROSCI.4491-12.2013","article-title":"An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3\u2013S1PR1-Akt pathway","volume":"33","author":"Guo","year":"2013","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/01.str.24.7.1000","article-title":"Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA bridging study group","volume":"24","author":"Haley","year":"1993","journal-title":"Stroke"},{"key":"B32","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s0196-0644(97)99996-0","article-title":"Myths regarding the NINDS rt-PA stroke trial: setting the record straight","volume":"30","author":"Haley","year":"1997","journal-title":"Ann. Emerg. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1161\/01.str.0000082721.62796.09","article-title":"Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke","volume":"34","author":"Higashida","year":"2003","journal-title":"Stroke"},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0140-6736(95)91179-0","article-title":"Termination of trial of streptokinase in severe acute ischaemic stroke","volume":"345","author":"Hommel","year":"1995","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/strokeaha.107.483131","article-title":"The interventional management of stroke (IMS) II study","volume":"38","author":"IMS II Trial Investigators","year":"2007","journal-title":"Stroke"},{"key":"B36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/01.str.0000121641.77121.98","article-title":"Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the interventional management of stroke study","volume":"35","author":"IMS Study Investigators","year":"2004","journal-title":"Stroke"},{"key":"B37","doi-asserted-by":"publisher","first-page":"i66","DOI":"10.1136\/neurintsurg-2013-010739","article-title":"Intra-arterial reperfusion strategies in acute ischemic stroke","volume":"5","author":"Jadhav","year":"2013","journal-title":"J. Neurointerv. Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart association\/American stroke association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/wnl.0b013e3181b9c847","article-title":"Good clinical outcome after ischemic stroke with successful revascularization is time-dependent","volume":"73","author":"Khatri","year":"2009","journal-title":"Neurology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/nejmoa1212793","article-title":"A trial of imaging selection and endovascular treatment for ischemic stroke","volume":"368","author":"Kidwell","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1161\/STROKEAHA.109.561274","article-title":"First food and drug administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke)","volume":"40","author":"Levy","year":"2009","journal-title":"Stroke"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/nm1122","article-title":"Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C","volume":"10","author":"Liu","year":"2004","journal-title":"Nat. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase 1 safety, tolerability and pharmacokinetics of 3K3A-APC in healthy adult volunteers","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B44","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1212\/wnl.42.5.976","article-title":"Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke","volume":"42","author":"Mori","year":"1992","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American heart association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group","volume":"333","author":"National Institute of Neurological Disorders and Stroke","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/s0140-6736(12)61299-9","article-title":"Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial","volume":"380","author":"Nogueira","year":"2012","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/strokeaha.108.544957","article-title":"The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease","volume":"40","author":"Penumbra Pivotal Stroke Trial Investigators","year":"2009","journal-title":"Stroke"},{"key":"B48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1227\/01.neu.0000363148.49779.68","article-title":"Activated protein C is neuroprotective and mediates new blood vessel formation and neurogenesis after controlled cortical impact","volume":"66","author":"Petraglia","year":"2010","journal-title":"Neurosurgery"},{"key":"B49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.str.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke"},{"key":"B50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.str.0000196957.55928.ab","article-title":"Time is brain\u2014quantified","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015a","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1408827","article-title":"Prehospital use of magnesium sulfate as neuroprotection in acute stroke","volume":"372","author":"Saver","year":"2015b","journal-title":"N. Engl. J. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/s0140-6736(12)61384-1","article-title":"Solitaire flow restoration device versus the Merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial","volume":"380","author":"Saver","year":"2012","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/circoutcomes.111.000303","article-title":"Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals","volume":"6","author":"Schwamm","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/01.cir.103.13.1799","article-title":"Anti-inflammatory, antithrombotic and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke","volume":"103","author":"Shibata","year":"2001","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/strokeaha.107.497115","article-title":"Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial","volume":"39","author":"Smith","year":"2008","journal-title":"Stroke"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/01.str.0000171066.25248.1d","article-title":"Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial","volume":"36","author":"Smith","year":"2005","journal-title":"Stroke"},{"key":"B58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.EEM.0000428925.65534.eb","article-title":"Breaking news: the \u2018biggest, baddest\u2019 controversy in EM","volume":"35","author":"SoRelle","year":"2013","journal-title":"Emerg. Med. News"},{"key":"B1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/nejm198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. TIMI study group","volume":"312","author":"Thrombolysis in Myocardial Infarction","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"12788","DOI":"10.1523\/jneurosci.3485-08.2008","article-title":"Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1","volume":"28","author":"Thiyagarajan","year":"2008","journal-title":"J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1161\/strokeaha.113.000731","article-title":"Novel approaches to neuroprotection trials in acute ischemic stroke","volume":"44","author":"Tymianski","year":"2013","journal-title":"Stroke"},{"key":"B61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/01.str.26.4.581","article-title":"Does arterial recanalization improve outcome in carotid territory stroke?","volume":"26","author":"von Kummer","year":"1995","journal-title":"Stroke"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1161\/strokeaha.108.536680","article-title":"Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity","volume":"40","author":"Wang","year":"2009","journal-title":"Stroke"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.2174\/138161212802430413","article-title":"Preclinical safety and pharmacokinetic profile of 3K3A-Apc, a novel, modified activated protein C for ischemic stroke","volume":"18","author":"Williams","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"B64","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tins.2011.01.005","article-title":"Cytoprotective protein C pathways and implications for stroke and neurological disorders","volume":"34","author":"Zlokovic","year":"2011","journal-title":"Trends Neurosci."},{"key":"B65","volume-title":"Safety Evaluation of 3K3A-APC in Ischemic Stroke (RHAPSODY).","author":"ZZ Biotech LLC","year":"2015"}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"deposited":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T13:37:32Z","timestamp":1443793052000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fncel.2015.00344\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":65,"URL":"https:\/\/doi.org\/10.3389\/fncel.2015.00344","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}